Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Survival and Treatment Patterns in Stage III Inflammatory and Noninflammatory Breast Cancer.
Journal: JAMA network open
Published: April 09, 2026
ASO Visual Abstract: Breast Reconstruction for Inflammatory Breast Cancer: Improving Patient-Reported Outcomes in a High-Risk Population.
Journal: Annals of surgical oncology
Published: January 17, 2026
Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer.
Journal: ESMO open
Published: November 04, 2025
ASO Author Reflections: Beyond Survival: Restoring Quality of Life in Inflammatory Breast Cancer.
Journal: Annals of surgical oncology
Published: October 23, 2025
Assessing the accuracy of inflammatory breast cancer self-reported diagnoses through the metastatic breast cancer project from the count me in initiative database.
Journal: Breast cancer research and treatment
Published: September 16, 2025
Outcomes of patients with de novo oligometastatic breast cancer treated with curative intent at a single institution.
Journal: Breast cancer research and treatment
Published: September 10, 2025
Preliminary Efficacy/Feasibility Study of a Breast Cancer-Related Lymphedema Prospective Screening and Early Intervention Program at the Dana-Farber Brigham Cancer Center.
Journal: Journal of clinical medicine
Published: August 08, 2025
The Clinicopathologic Features of Inflammatory Breast Carcinoma (IBC) With Lobular Features.
Journal: The American journal of surgical pathology
Published: July 03, 2025
Breast Reconstruction for Inflammatory Breast Cancer: Improving Patient-Reported Outcomes in a High-Risk Population.
Journal: Annals of surgical oncology
Published: May 19, 2025
Neoadjuvant HER2-targeted regimens with or without anthracyclines for HER2-positive inflammatory breast cancer: a multicenter retrospective study.
Journal: Breast cancer research and treatment
Published: May 10, 2025
Neoadjuvant therapy with eribulin, doxorubicin and cyclophosphamide for patients with HER2-negative inflammatory breast cancer: a phase II study.
Journal: Breast cancer research : BCR
Published: January 30, 2025
Last Updated: 09/26/2026